QA: Paratek Pharmaceuticals Inc in us_pharma/2016

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001178711_2017_Paratek_Pharmaceuticals_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001178711, Paratek Pharmaceuticals Inc

  xvar xval
0 AssetsCurrent 132,100,000
1 IntangibleAssetsNetIncludingGoodwill 1,844,000
2 PropertyPlantAndEquipmentNet 1,188,000
3 remainder_Assets 600,000
4 LiabilitiesCurrent 20,412,000
5 LiabilitiesNoncurrent 43,073,000
6 remainder_Liabilities 655,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 25,761,205
9 ResearchAndDevelopmentExpense 133,936,970
10 remainder_Expenses 1,513,145
11 remainder_Revenues 24,759
12 remainder_NetIncome 596,031
13 remainder_ComprehensiveNetIncome -8,853
  yvar yval
0 Assets 135,732,000
1 Liabilities 64,140,000
2 Expenses 161,211,320
3 Revenues 24,759
4 StockholdersEquity 71,592,000
5 NetIncome -160,590,530
6 ComprehensiveNetIncome -160,594,956
7 BaseVar 180,856,482
8 EconomicCapitalRatiobeforeLimitedLiability -0.0453
9 EconomicCapitalRatio 1.41

Edgar->Model Mapping

Feature Distribution

Change over Time